Antibiotic News and Research

RSS

Antibiotics are drugs used to treat infections caused by bacteria and other microorganisms.

Polyphor, Roche agree to develop and commercialize antibiotic for bacterial infections

Polyphor Ltd, a privately held pharmaceutical company, and Roche announced today that they have entered into an exclusive worldwide license agreement to develop and commercialize Polyphor's investigational macrocycle antibiotic, POL7080, for patients suffering from bacterial infections caused by Pseudomonas aeruginosa.

4 Nov 2013

Honey may be detrimental for patients with type 2 diabetes

Honey may be detrimental for patients with type 2 diabetes because of the great quantities of sugars it contains.

31 Oct 2013

Hand hygiene compliance improves to 89%, study finds

How often do you clean your hands? A study at Rhode Island Hospital observed staff on 161,526 occasions to monitor how often they cleaned their hands (ie, hand hygiene) between July 2008 to December 2012 and found that hand hygiene compliance improved from 60 percent to 89 percent. The study is published online in advance of print in the journal Infection Control and Hospital Epidemiology.

30 Oct 2013

Identifying gaps in infection prevention practices may help improve patient safety, shows study

Identifying gaps in infection prevention practices may yield opportunities for improved patient safety, according to a survey published in the November issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).

30 Oct 2013

Researchers develop new substance that quickly and effectively kills multi-resistant bacteria

In Europe alone, more than 25,000 people die each year from infections caused by multi-resistant bacteria. Researchers from University of Copenhagen have now developed and characterized a substance that quickly and effectively kills the virulent bacteria. The substance employs a multifunctional mechanism that reduces the risk of antibiotic resistance. The findings have recently been published in the scientific journal Chemistry & Biology.

30 Oct 2013

The Joint Commission names HNMC as ‘Top Performer on Key Quality Measures for 2012’

Holy Name Medical Center (HNMC) was named one of the nation's Top Performers on Key Quality Measures for 2012 by The Joint Commission, the leading accreditor of healthcare organizations in America.

30 Oct 2013

Queen's University is lead partner in £6M global research program to develop new ways to treat CF

Queen's University Belfast is a lead partner in a new -6 million (euro) global research programme to develop new ways to treat Cystic Fibrosis.

30 Oct 2013

Dermatologists provide list of specific treatments, procedures not required for medical care

The American Academy of Dermatology today released its list of specific treatments and procedures related to skin health and care that are not always necessary.

29 Oct 2013

Low birth weight infants more susceptible to invasive infections

Low birth weight infants are host to numerous microorganisms immediately after birth, and the microbiomes of their mouths and gut start out very similar but differentiate significantly by day 15 according to a study published in mBio-, the online open-access journal of the American Society for Microbiology.

29 Oct 2013

Sore throat clinical score boosts effective antibiotic use

Research published in the BMJ shows that clinical score is as good a guide for antibiotic prescribing as rapid streptococcal antigen detection tests in patients presenting to primary care with sore throat.

28 Oct 2013

MRSA musculoskeletal infections increasing among children

Pediatric musculoskeletal Staphylococcus aureus bacterial infections have been evolving over the past decade, with more children diagnosed with the more virulent, methicillin-resistant Staphylococcus aureus today than 10 years ago.

28 Oct 2013

Researchers identify obesity as possible risk factor for clostridium difficile infection

Researchers from Boston Medical Center and Boston University School of Medicine have identified obesity as a possible risk factor for clostridium difficile infection. These findings, which appear online in Emerging Infectious Diseases, may contribute to improved clinical surveillance of those at highest risk of disease.

25 Oct 2013

Type 1 diabetes modifies communication between central nervous system and bone marrow

A new University of Sydney study has found that having Type 1 diabetes alters the normal communication between the human central nervous system and bone marrow, causing inflammatory effects and further disease.

24 Oct 2013

Three researchers team up to develop framework to help prevent hospital infections

Two researchers at the University of Maryland's Robert H. Smith School of Business have teamed up with a researcher at American University to develop a framework to help prevent costly and deadly infections acquired by hospitalized patients.

23 Oct 2013

COPD treatments: an interview with Professor Price, University of Aberdeen

The first thing is that we can’t cure COPD. The problem we have with COPD is that the process itself is not treatable, certainly not once it gets to the extent that it’s advanced.

22 Oct 2013

Dentist offers advanced teeth whitening options

Los Angeles tooth whitening dentist, Dr. Kevin Sands, offers advanced teeth whitening options to help patients erase many years' worth of stains from even the most discolored teeth.

19 Oct 2013

Anacor Pharmaceuticals appoints arbitrator to resolve its dispute with Valeant Pharmaceuticals

Anacor Pharmaceuticals (NASDAQ:ANAC) today announced that the arbitrator appointed to resolve its dispute with Valeant Pharmaceuticals, Inc. (Valeant), successor in interest to Dow Pharmaceutical Sciences, Inc. (DPS), has issued an Interim Final Award in favor of Anacor, awarding Anacor $100 million in damages as well as all costs of the arbitration and reasonable attorney's fees.

18 Oct 2013

Atorvastatin drug plus zoledronic acid may help treat toxoplasmosis

Researchers at the University of Georgia have discovered that a combination of two commonly prescribed drugs used to treat high cholesterol and osteoporosis may serve as the foundation of a new treatment for toxoplasmosis, a parasitic infection caused by the protozoan Toxoplasma gondii. They published their findings recently in PLOS Pathogens.

18 Oct 2013

Neutra working to help end staph infections in locker rooms

With football season now in full swing, a dangerous, highly resistant strain of staph infections is plaguing locker rooms across the country, potentially costing organizations such as the NFL and NCAA millions of dollars. Neutra Corp., a growing provider of all-natural wellness solutions, is working to help end the costly epidemic.

17 Oct 2013

AmpliPhi, University of Leicester partner to develop novel bacteriophage therapy against C. difficile

AmpliPhi BioSciences Corporation, the leader in the development of bacteriophage-based antibacterial therapies to treat antibiotic resistant infections, announces it has entered into Collaboration and License Agreements with UK-based University of Leicester to develop a novel bacteriophage therapy targeting Clostridium difficile, a serious gastrointestinal infection for which new treatments are urgently required.

17 Oct 2013

Antibiotic News and Research

Further Reading

Polyphor, Roche agree to develop and commercialize antibiotic for bacterial infections

Honey may be detrimental for patients with type 2 diabetes

Hand hygiene compliance improves to 89%, study finds

Identifying gaps in infection prevention practices may help improve patient safety, shows study

Researchers develop new substance that quickly and effectively kills multi-resistant bacteria

The Joint Commission names HNMC as ‘Top Performer on Key Quality Measures for 2012’

Queen's University is lead partner in £6M global research program to develop new ways to treat CF

Dermatologists provide list of specific treatments, procedures not required for medical care

Low birth weight infants more susceptible to invasive infections

Sore throat clinical score boosts effective antibiotic use

MRSA musculoskeletal infections increasing among children

Researchers identify obesity as possible risk factor for clostridium difficile infection

Type 1 diabetes modifies communication between central nervous system and bone marrow

Three researchers team up to develop framework to help prevent hospital infections

COPD treatments: an interview with Professor Price, University of Aberdeen

Dentist offers advanced teeth whitening options

Anacor Pharmaceuticals appoints arbitrator to resolve its dispute with Valeant Pharmaceuticals

Atorvastatin drug plus zoledronic acid may help treat toxoplasmosis

Neutra working to help end staph infections in locker rooms

AmpliPhi, University of Leicester partner to develop novel bacteriophage therapy against C. difficile

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News